Novartis concludes BioCamp event in Slovenia for promising students

  • The twelfth BioCamp, a scientific event designed to connect students of science, economics and engineering with renowned experts and leading managers, concluded with the award ceremony for the best students.
  • The theme of the online event was new methods of healing and co-creating medicine in the age of the metaverse. The event was attended by 36 students from 16 countries.
  • Novartis in Slovenia is bringing together some of the company's key strategic focuses - supporting innovation, nurturing young talent and connecting business and academia.
30. 9. 2022

Novartis in Slovenia hosted 36 of the most promising science, economics and engineering students from the region and beyond at the 12th BioCamp. The traditional event gives young people from all over the world an insight into the pharmaceutical industry, offers a unique platform for networking and opens doors to career opportunities.

Co-creating medicine in the age of the  metaverse

The theme of the online event was New modalities in therapies and reimagining medicine in the age of metaverse. Young talents learned about the opportunities and challenges that digitalisation, automation and artificial intelligence bring to pharmaceuticals. "Digital transformation and the latest technologies are key to better patient care, cost-efficiency, increased transparency, better manufacturing and faster drug development. Digitisation, automation, predictive analytics and virtual technology have become part of everyday life at Novartis' state-of-the-art facilities in Slovenia, opening up opportunities for high value-added jobs. Talents with expertise in life sciences as well as in entrepreneurship and information technology are key to success today," said Janko Ignjatović, PhD,  Head of Development Projects at the Sandoz Development Centre Slovenia and Head  of the BioCamp Organising Committee.

BioCamp opens the door to the world of pharmaceutics

In twelve years, BioCamp has brought together almost 500 young talents, more than 50 of whom have joined Novartis. "BioCamp is a unique event that opens the door to the world of pharma for the best students from the region and beyond. It is an invaluable opportunity to network with top experts from Slovenia and abroad, as well as other promising students. This year, we have again intertwined business and academia in the event, an important partnership that Novartis Slovenia often relies on to find answers to the pharmaceutical industry's most pressing challenges. As a company that is constantly looking for prospective talent, BioCamp allows us to introduce them to the current challenges in pharmaceuticals and the values of Novartis in Slovenia," added Janko Ignjatović, PhD, a former BioCamp participant himself and today a project manager at Sandoz Development Centre Slovenia and chairman of the BioCamp organizing committee.

In addition to lectures and workshops, participants had the opportunity to try their hand at solving real challenges in the pharmaceutical industry and presented their solutions in groups to an expert panel. The winning group consisted of Aleksandra Bugakova, Vito Kovač, Tjaša Mlakar, Mustafa Abacıoğlu, Nada Tarek in Teodora Tomović.

Novartis  in Slovenia is known for its HR practices

Novartis in Slovenia is one of the largest and most recognised employers in the country, which also impresses with its innovative HR practices. The BioCamp project is a multi-award-winning HR initiative, most recently as the Best HR Practice 2020 - Honourable Mention at the International Conference on the Development of Organisational Science.

The company also boasts the title of Most Reputable Employer 2021 and the international "Top Employer" certification, which recognises companies with excellent HR practices and employee development programmes. "Innovative, inquisitive and agile talent is key to running a successful business and fulfilling our mission to improve the quality of life for people around the world. At Novartis Slovenia, we understand that to remain among the best, we need to attract the best people to our ranks, which requires innovative approaches. Over the past twelve years, BioCamp has developed into an established HR practice that continues to push boundaries and set new standards. The changes that Industry 4.0 is bringing to the pharmaceutical industry are thus also reflected in the execution of the event, where we have incorporated state-of-the-art digital and technological solutions that expand networking and collaboration opportunities for participants," said Darja Ferčej Temeljotov, PhD, Project Manager at Novartis Strategic Programmes in Slovenia.

* * *

Novartis is the leading provider of medicines in Slovenia, where Lek d.d.,Novartis Pharma Services Inc. and Sandoz d.d., operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role inNovartis' organizational structure, especially in the Novartis Technical Operations, Global Drug Development, Novartis Business Services, and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees.Novartis invested in Slovenia more than EUR 3 billion since 2003.

About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2021 sales of USD 9.6 billion.

About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world.
 Find out more at

* * *

This press release contains statements and forecasts of future business operations. The forecasts include estimates based on all theinformation currently available to us. Should these forecasts prove unreliable, the actual results of business operations could be different from those expected.

- end -

For further information, please contact:
Gregor Makuc
Communication & External Engagement
Lek Pharmaceuticals d.d.
Telephone: 01 580 22 43